New initiatives by the federal government aim at making the healthcare industry’s pricing models more transparent. However, healthcare providers and hospitals have pushed back against such efforts arguing that:
such pricing information qualifies as trade secrets;
publication of prices would put unnecessary hardship on healthcare providers and hospitals;
such rules will not have the intended effect of saving money for patients; and
such requirements may ultimately make health care services more expensive in the long run.
Read about how healthcare and pharmaceutical companies are pushing back on pricing disclosures.